$INGR

Fischer David B sold $170K of INGR

Fischer David B sold 1,662 shares of Ingredion Inc (INGR) at $102.31 ($0.17M total) on 2026-08-05.

Original reporting
SEC EDGAR · Fischer David B
Published Aug 6, 2026, 5:49 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 5:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$INGR
Neutral
medium confidence
Mentioned
$INGR
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$INGRNeutralLow
01

Why it matters

The only new fact is the reported sale size, price, and post-transaction holdings. There is no guidance, earnings, deal, or regulatory development included.

02

Market read

Traders may note insider selling as a minor sentiment input, but the disclosed value is small and lacks fundamental catalysts.

03

What to watch

The filing states no pre-arranged 10b5-1 plan, but the article does not provide context on other holdings, compensation, or whether multiple transactions occurred around the same time.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-06 after-hours/late session; transaction dated 2026-08-05

Background

This is an SEC Form 4 insider transaction disclosure for Ingredion Inc, reported by a director.

Company-level read

Ticker impact

$INGRNeutralMedium confidence
Context

Ingredion director David B Fischer filed a Form 4 selling 1,662 shares at $102.31 on 2026-08-05, totaling about $170k.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment.

Evidence & confidence

The disclosure is an insider transaction (small dollar value) without accompanying operational, financial, or regulatory catalysts. Insider sales can be informational, but this size and lack of stated plan details typically do not drive material repricing.

Market effects

No clear sector read-through from a single, small insider sale.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification, taxes, or pre-existing personal liquidity needs, so it may not signal reduced confidence in Ingredion’s outlook.

Key entities

  • Ingredion Inc

    Subject of the Form 4 insider sale disclosure.

  • David B Fischer

    Director who sold 1,662 shares in an open-market transaction.

Related articles

$INGRMedAI 8/10

Ingredion-Tate & Lyle $3.6bn deal cleared in Brazil

Brazil’s competition authority cleared Ingredion’s proposed $3.6 billion acquisition of Tate & Lyle under a fast-track review. The deal was notified July 20 and approved after the agency’s assessment. The clearance removes a regulatory hurdle for the transaction, which could affect both companies’ deal-related outlook.

$INGRMed

Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth

Ingredion (INGR) reported Q2 2026 adjusted EPS of $2.82, above the $2.73 Zacks estimate, with net sales up 0.9% to $1.85B. Texture & Healthful Solutions volumes rose 7%. Gross profit and operating income declined due to Argo manufacturing issues, higher input costs, and Mexico FX/macro headwinds. 2026 guidance was reaffirmed.

$INGRMed

INGR Q2 Deep Dive: Texture & Healthful Solutions Growth and Margin Pressures Shape Outlook

Ingredion (NYSE: INGR) reported Q2 CY2026 revenue of $1.85B, flat year on year and slightly above analysts’ $1.83B estimate. Non-GAAP EPS was $2.82, 3.6% above consensus. Management lowered full-year adjusted EPS guidance midpoint to $10.60. Operating margin fell to 10.2% from 14.8% a year earlier, citing Argo facility issues and input-cost pressures, while Texture & Healthful Solutions volume grew for nine straight quarters.

$INGRMed

Ingredion Q2 2026 slides: volume growth masks margin pressure

Ingredion (NYSE:INGR) reported Q2 2026 adjusted EPS of $2.82 on revenue of $1.85B, slightly above estimates. Net sales rose 1% but adjusted operating income fell 5% to $258M as gross margin dropped 300 bps to 23.0%. The company cited margin pressure from higher input costs and Argo facility issues, while Texture & Healthful Solutions volume grew 7%.

$INGRHighAI 9/10

Ingredion to buy Tate & Lyle for $3.6 billion

Ingredion Inc. will acquire Tate & Lyle PLC for about £2.7 billion, or $3.6 billion, to expand capabilities in texturants, sugar reduction and fortification, according to Ingredion. The deal, announced May 14, would create a combined business with sales near $10 billion. Tate & Lyle FY ended March 31 sales were £2.0 billion, down 3%.